
According to the draft resolution published on March 24, the Federal Service for Supervision of Healthcare (Roszdravnadzor) is empowered to monitor the volume of drugs included in the list of vital and essential drugs (Vital and Essential Drugs) in circulation, as well as their compliance with the existing need.